HEADER HYDROLASE/HYDROLASE INHIBITOR 08-DEC-14 4X6M TITLE FACTOR XIA IN COMPLEX WITH THE INHIBITOR 1-{(1S)-1-[4-(3-AMINO-1H- TITLE 2 INDAZOL-6-YL)-5-CHLORO-1H-IMIDAZOL-2-YL]-2-PHENYLETHYL}-3-[2- TITLE 3 (AMINOMETHYL)-5-CHLOROBENZYL]UREA COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR XI, LIGHT CHAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FXI,PLASMA THROMBOPLASTIN ANTECEDENT,PTA; COMPND 5 EC: 3.4.21.27; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: F11; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET14B KEYWDS SERINE PROTEASE, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.WEI REVDAT 3 01-APR-15 4X6M 1 JRNL REVDAT 2 18-MAR-15 4X6M 1 JRNL REVDAT 1 18-FEB-15 4X6M 0 JRNL AUTH D.J.PINTO,J.M.SMALLHEER,J.R.CORTE,E.J.AUSTIN,C.WANG,T.FANG, JRNL AUTH 2 L.M.SMITH,K.A.ROSSI,A.R.RENDINA,J.M.BOZARTH,G.ZHANG,A.WEI, JRNL AUTH 3 V.RAMAMURTHY,S.SHERIFF,J.E.MYERS,P.E.MORIN,J.M.LUETTGEN, JRNL AUTH 4 D.A.SEIFFERT,M.L.QUAN,R.R.WEXLER JRNL TITL STRUCTURE-BASED DESIGN OF INHIBITORS OF COAGULATION FACTOR JRNL TITL 2 XIA WITH NOVEL P1 MOIETIES. JRNL REF BIOORG.MED.CHEM.LETT. V. 25 1635 2015 JRNL REFN ESSN 1464-3405 JRNL PMID 25728130 JRNL DOI 10.1016/J.BMCL.2015.01.028 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.L.QUAN,P.C.WONG,C.WANG,F.WOERNER,J.M.SMALLHEER, REMARK 1 AUTH 2 F.A.BARBERA,J.M.BOZARTH,R.L.BROWN,M.R.HARPEL,J.M.LUETTGEN, REMARK 1 AUTH 3 P.E.MORIN,T.PETERSON,V.RAMAMURTHY,A.R.RENDINA,K.A.ROSSI, REMARK 1 AUTH 4 C.A.WATSON,A.WEI,G.ZHANG,D.SEIFFERT,R.R.WEXLER REMARK 1 TITL TETRAHYDROQUINOLINE DERIVATIVES AS POTENT AND SELECTIVE REMARK 1 TITL 2 FACTOR XIA INHIBITORS. REMARK 1 REF J.MED.CHEM. V. 57 955 2014 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 24405333 REMARK 1 DOI 10.1021/JM401670X REMARK 1 REFERENCE 2 REMARK 1 AUTH J.J.HANGELAND,T.J.FRIENDS,K.A.ROSSI,J.M.SMALLHEER,C.WANG, REMARK 1 AUTH 2 Z.SUN,J.R.CORTE,T.FANG,P.C.WONG,A.R.RENDINA,F.A.BARBERA, REMARK 1 AUTH 3 J.M.BOZARTH,J.M.LUETTGEN,C.A.WATSON,G.ZHANG,A.WEI, REMARK 1 AUTH 4 V.RAMAMURTHY,P.E.MORIN,G.S.BISACCHI,S.SUBRAMANIAM, REMARK 1 AUTH 5 P.ARUNACHALAM,A.MATHUR,D.A.SEIFFERT,R.R.WEXLER,M.L.QUAN REMARK 1 TITL PHENYLIMIDAZOLES AS POTENT AND SELECTIVE INHIBITORS OF REMARK 1 TITL 2 COAGULATION FACTOR XIA WITH IN VIVO ANTITHROMBOTIC ACTIVITY. REMARK 1 REF J.MED.CHEM. V. 57 9915 2014 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 25405503 REMARK 1 DOI 10.1021/JM5010607 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.R.CORTE,T.FANG,J.J.HANGELAND,T.J.FRIENDS,A.R.RENDINA, REMARK 1 AUTH 2 J.M.LUETTGEN,J.M.BOZARTH,F.A.BARBERA,K.A.ROSSI,A.WEI, REMARK 1 AUTH 3 V.RAMAMURTHY,P.E.MORIN,D.A.SEIFFERT,R.R.WEXLER,M.L.QUAN REMARK 1 TITL PYRIDINE AND PYRIDINONE-BASED FACTOR XIA INHIBITORS. REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 25 925 2015 REMARK 1 REFN ESSN 1464-3405 REMARK 1 PMID 25592713 REMARK 1 DOI 10.1016/J.BMCL.2014.12.050 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 15390 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.760 REMARK 3 FREE R VALUE TEST SET COUNT : 1040 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.57 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.69 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2737 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2150 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2549 REMARK 3 BIN R VALUE (WORKING SET) : 0.2123 REMARK 3 BIN FREE R VALUE : 0.2472 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.87 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 188 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1857 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 79 REMARK 3 SOLVENT ATOMS : 154 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.53 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.70870 REMARK 3 B22 (A**2) : -3.70870 REMARK 3 B33 (A**2) : 7.41730 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.276 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.270 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.208 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.252 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.203 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.931 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.900 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2005 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2726 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 669 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 42 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 334 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2005 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 249 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2362 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.10 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.69 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.83 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4X6M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-DEC-14. REMARK 100 THE DEPOSITION ID IS D_1000205175. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-MAR-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MICROMAX CONFOCAL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 92 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15480 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 10.30 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.15700 REMARK 200 FOR THE DATA SET : 17.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.60 REMARK 200 R MERGE FOR SHELL (I) : 0.52900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: FACTOR XIA DOUBLE MUTANT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM SODIUM ACETATE, PH 4.6, REMARK 280 26%(W/V) MEPEG2000, 200 MM AMMONIUM SULFATE, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.93333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 35.46667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 35.46667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 70.93333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CHAIN A REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 S SO4 A 302 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 420 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 246 REMARK 465 HIS A 247 REMARK 465 HIS A 248 REMARK 465 HIS A 249 REMARK 465 HIS A 250 REMARK 465 HIS A 251 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 126 CG CD CE NZ REMARK 470 ARG A 129 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 130 CG OD1 ND2 REMARK 470 ARG A 148 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 185 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 214 -71.97 -116.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 3Y3 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 308 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 309 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 310 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 311 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4X6N RELATED DB: PDB REMARK 900 RELATED ID: 4X6O RELATED DB: PDB REMARK 900 RELATED ID: 4X6P RELATED DB: PDB DBREF 4X6M A 16 245 UNP P03951 FA11_HUMAN 388 625 SEQADV 4X6M GLY A 113 UNP P03951 ASN 491 ENGINEERED MUTATION SEQADV 4X6M GLY A 115 UNP P03951 THR 493 ENGINEERED MUTATION SEQADV 4X6M HIS A 246 UNP P03951 EXPRESSION TAG SEQADV 4X6M HIS A 247 UNP P03951 EXPRESSION TAG SEQADV 4X6M HIS A 248 UNP P03951 EXPRESSION TAG SEQADV 4X6M HIS A 249 UNP P03951 EXPRESSION TAG SEQADV 4X6M HIS A 250 UNP P03951 EXPRESSION TAG SEQADV 4X6M HIS A 251 UNP P03951 EXPRESSION TAG SEQRES 1 A 244 ILE VAL GLY GLY THR ALA SER VAL ARG GLY GLU TRP PRO SEQRES 2 A 244 TRP GLN VAL THR LEU HIS THR THR SER PRO THR GLN ARG SEQRES 3 A 244 HIS LEU CYS GLY GLY SER ILE ILE GLY ASN GLN TRP ILE SEQRES 4 A 244 LEU THR ALA ALA HIS CYS PHE TYR GLY VAL GLU SER PRO SEQRES 5 A 244 LYS ILE LEU ARG VAL TYR SER GLY ILE LEU ASN GLN SER SEQRES 6 A 244 GLU ILE LYS GLU ASP THR SER PHE PHE GLY VAL GLN GLU SEQRES 7 A 244 ILE ILE ILE HIS ASP GLN TYR LYS MET ALA GLU SER GLY SEQRES 8 A 244 TYR ASP ILE ALA LEU LEU LYS LEU GLU THR THR VAL GLY SEQRES 9 A 244 TYR GLY ASP SER GLN ARG PRO ILE CYS LEU PRO SER LYS SEQRES 10 A 244 GLY ASP ARG ASN VAL ILE TYR THR ASP CYS TRP VAL THR SEQRES 11 A 244 GLY TRP GLY TYR ARG LYS LEU ARG ASP LYS ILE GLN ASN SEQRES 12 A 244 THR LEU GLN LYS ALA LYS ILE PRO LEU VAL THR ASN GLU SEQRES 13 A 244 GLU CYS GLN LYS ARG TYR ARG GLY HIS LYS ILE THR HIS SEQRES 14 A 244 LYS MET ILE CYS ALA GLY TYR ARG GLU GLY GLY LYS ASP SEQRES 15 A 244 ALA CYS LYS GLY ASP SER GLY GLY PRO LEU SER CYS LYS SEQRES 16 A 244 HIS ASN GLU VAL TRP HIS LEU VAL GLY ILE THR SER TRP SEQRES 17 A 244 GLY GLU GLY CYS ALA GLN ARG GLU ARG PRO GLY VAL TYR SEQRES 18 A 244 THR ASN VAL VAL GLU TYR VAL ASP TRP ILE LEU GLU LYS SEQRES 19 A 244 THR GLN ALA VAL HIS HIS HIS HIS HIS HIS HET 3Y3 A 301 64 HET SO4 A 302 5 HET EDO A 303 4 HET EDO A 304 4 HET EDO A 305 4 HET EDO A 306 4 HET EDO A 307 4 HET EDO A 308 4 HET EDO A 309 4 HET EDO A 310 4 HET EDO A 311 4 HETNAM 3Y3 1-{(1S)-1-[4-(3-AMINO-1H-INDAZOL-6-YL)-5-CHLORO-1H- HETNAM 2 3Y3 IMIDAZOL-2-YL]-2-PHENYLETHYL}-3-[2-(AMINOMETHYL)-5- HETNAM 3 3Y3 CHLOROBENZYL]UREA HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 3Y3 C27 H26 CL2 N8 O FORMUL 3 SO4 O4 S 2- FORMUL 4 EDO 9(C2 H6 O2) FORMUL 13 HOH *154(H2 O) HELIX 1 AA1 ALA A 55 TYR A 58B 5 6 HELIX 2 AA2 SER A 62 LYS A 64 5 3 HELIX 3 AA3 ASN A 72 ILE A 76 5 5 HELIX 4 AA4 MET A 96 GLY A 100 5 5 HELIX 5 AA5 LYS A 126 ASN A 130 5 5 HELIX 6 AA6 THR A 164 TYR A 171 1 9 HELIX 7 AA7 TYR A 234 GLN A 243 1 10 SHEET 1 AA1 8 THR A 20 ALA A 21 0 SHEET 2 AA1 8 GLN A 156 LYS A 159 -1 O LYS A 157 N THR A 20 SHEET 3 AA1 8 CYS A 136 GLY A 140 -1 N GLY A 140 O GLN A 156 SHEET 4 AA1 8 PRO A 198 HIS A 203 -1 O SER A 200 N TRP A 137 SHEET 5 AA1 8 VAL A 206 TRP A 215 -1 O VAL A 206 N HIS A 203 SHEET 6 AA1 8 GLY A 226 ASN A 230 -1 O VAL A 227 N TRP A 215 SHEET 7 AA1 8 MET A 180 ALA A 183 -1 N ILE A 181 O TYR A 228 SHEET 8 AA1 8 LEU A 162 VAL A 163 -1 N VAL A 163 O CYS A 182 SHEET 1 AA2 7 GLN A 30 THR A 35 0 SHEET 2 AA2 7 ARG A 39 GLY A 48 -1 O LEU A 41 N LEU A 33 SHEET 3 AA2 7 TRP A 51 THR A 54 -1 O LEU A 53 N SER A 45 SHEET 4 AA2 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54 SHEET 5 AA2 7 PHE A 83 ILE A 90 -1 N ILE A 89 O LEU A 105 SHEET 6 AA2 7 LEU A 65A TYR A 67 -1 N VAL A 66 O PHE A 83 SHEET 7 AA2 7 GLN A 30 THR A 35 -1 N HIS A 34 O ARG A 65B SSBOND 1 CYS A 42 CYS A 58 1555 1555 2.04 SSBOND 2 CYS A 136 CYS A 201 1555 1555 2.05 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.03 SSBOND 4 CYS A 191 CYS A 219 1555 1555 2.06 CISPEP 1 SER A 36A PRO A 36B 0 -4.00 SITE 1 AC1 28 ARG A 39 HIS A 40 LEU A 41 HIS A 57 SITE 2 AC1 28 TYR A 143 ILE A 151 ASP A 189 ALA A 190 SITE 3 AC1 28 CYS A 191 LYS A 192 GLY A 193 ASP A 194 SITE 4 AC1 28 SER A 195 THR A 213 SER A 214 TRP A 215 SITE 5 AC1 28 GLY A 216 GLY A 218 GLY A 226 VAL A 227 SITE 6 AC1 28 TYR A 228 EDO A 310 HOH A 437 HOH A 457 SITE 7 AC1 28 HOH A 470 HOH A 538 HOH A 541 HOH A 547 SITE 1 AC2 2 ARG A 170 ARG A 184B SITE 1 AC3 5 ASN A 49 THR A 111 VAL A 112 GLY A 113 SITE 2 AC3 5 TYR A 114 SITE 1 AC4 5 ARG A 24 SER A 99 LYS A 175 HOH A 433 SITE 2 AC4 5 HOH A 436 SITE 1 AC5 8 ARG A 24 GLY A 25 TRP A 27 PRO A 28 SITE 2 AC5 8 ILE A 70 LEU A 71 SER A 117 HOH A 408 SITE 1 AC6 6 GLU A 98 TRP A 215 GLY A 216 GLU A 217 SITE 2 AC6 6 HOH A 423 HOH A 541 SITE 1 AC7 2 THR A 177 HIS A 178 SITE 1 AC8 2 GLY A 113 TYR A 114 SITE 1 AC9 7 GLU A 167 ARG A 170 GLY A 184 TYR A 184A SITE 2 AC9 7 GLU A 223 PRO A 225 HOH A 472 SITE 1 AD1 3 TYR A 143 LYS A 192 3Y3 A 301 SITE 1 AD2 3 THR A 164 ASN A 165 GLU A 166 CRYST1 78.900 78.900 106.400 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012674 0.007317 0.000000 0.00000 SCALE2 0.000000 0.014635 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009398 0.00000